United States · FDA National Drug Code directory

IMOVAX RABIES

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
49281-252_d3a946ba-6644-4574-9c5f-90f9b06e3867
Product NDC
49281-252
Form
KIT
Composition / generic term
RABIES VIRUS STRAIN PM-1503-3M ANTIGEN (PROPIOLACTONE INACTIVATED) and WATER
Labeler
Sanofi Vaccines US Inc.
Marketing category
BLA
Marketing start / end (source format)
20191025
Source listing expiry
20271231

Source-listed ingredients

Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 KIT in 1 PACKAGE (49281-252-51) * 1 mL in 1 VIAL, SINGLE-USE (49281-246-58) * 1 mL in 1 SYRINGE (49281-263-58) · 49281-252-51

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
IMOVAX RABIES — United States | Molindra Medicines